Trial intelligence / Profile preview

Topical cyclosporine for fingernail psoriasis

NL-OMON25326Active, not recruiting

Sponsor
Erasmus MC
Start
Jul 2006
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Randomised, double-blind trial of cyclosporine in nail psoriasis and psoriasis (2 arms), sponsored by Erasmus MC. Primary endpoint: Nail Psoriasis Severity Index. Started Jul 2006; status: active, not recruiting.

02

Drugs

cyclosporine
03

Conditions

nail psoriasispsoriasis

Beyond the preview

Go deeper on NL-OMON25326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call